Antares Pharma, Inc. - Strategy, SWOT and Corporate Finance Report

October 2023 | 42 pages | ID: A11480883F6EN
MarketLine

Abstracts

Antares Pharma, Inc. %li%Strategy, SWOT and Corporate Finance Report

Summary

Antares Pharma, Inc. %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Antares Pharma, Inc. (Antares or 'the company') is a drug device company that develops and markets self-injection pharmaceutical products and technologies. The company develops these products with its partners and is designed to provide functional and commercial advantages, such as reduced side effects, improved safety and efficacy and enhanced patient comfort and adherence. Its major technology includes VIBEX and VIBEX QuickShot pressure-assisted auto-injector systems. The company sells its products under VIBEX, ELESTRIN, and XYOSTED brand names. It also manages partnerships with various pharmaceutical companies to advance various product development programs. The company operates in the US, Europe and other regions worldwide. The company is headquartered in Ewing, New Jersey, the US.

Scope

• Detailed information on Antares Pharma, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Antares Pharma, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Antares Pharma, Inc. including a breakdown and examination of key business segments
• Intelligence on Antares Pharma, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Antares Pharma, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Antares Pharma, Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Antares Pharma, Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Antares Pharma, Inc.'s business structure, strategy and prospects.

Contents

Company Snapshot
Antares Pharma, Inc.: Company Overview
Antares Pharma, Inc.: Overview and Key Facts
Antares Pharma, Inc.: Overview
Antares Pharma, Inc.: Key Facts
Antares Pharma, Inc.: Key Employees
Antares Pharma, Inc.: Key Employee Biographies
Antares Pharma, Inc.: Major Products and Services
Antares Pharma, Inc.: Management Statement
Antares Pharma, Inc.: Locations and Subsidiaries
Antares Pharma, Inc.: Key Competitors
Antares Pharma, Inc.: Company Analysis
Antares Pharma, Inc.: Business Description
Antares Pharma, Inc.: SWOT Analysis
Antares Pharma, Inc.: SWOT Overview
Antares Pharma, Inc.: Strengths
Antares Pharma, Inc.: Weaknesses
Antares Pharma, Inc.: Opportunities
Antares Pharma, Inc.: Threats
Antares Pharma, Inc.: Corporate Financial Deals Activity
Antares Pharma, Inc.: Financial Deals Overview
Antares Pharma, Inc.: Targets and Partners
Antares Pharma, Inc.: Top Deals 2019 - 2023YTD*
Antares Pharma, Inc.: Advisors
Antares Pharma, Inc.: Top Legal Advisors
Antares Pharma, Inc.: Top Financial Advisors
Antares Pharma, Inc.: Partnership
Antares Pharma, Inc.: Divestments
Antares Pharma, Inc.: Private Equity and Ownership
Antares Pharma, Inc.: Recent Developments
Antares Pharma, Inc.: News and Events Summary
Antares Pharma, Inc.: Business Expansion
Antares Pharma, Inc.: Corporate Governance
Antares Pharma, Inc.: Financial Performance
Antares Pharma, Inc.: Market Developments
Antares Pharma, Inc.: Regulatory and Legal Events
Antares Pharma, Inc.: Research & Development
Antares Pharma, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Antares Pharma, Inc.: Key Facts
Table 2: Antares Pharma, Inc.: Key Employees
Table 3: Antares Pharma, Inc.: Locations and Subsidiaries
Table 4: Antares Pharma, Inc.: Key Competitors
Table 5: Antares Pharma, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 6: Antares Pharma, Inc.: Targets and Partners
Table 7: Antares Pharma, Inc.: Top Deals 2019 - 2023YTD*
Table 8: Antares Pharma, Inc.: Legal Advisor Ranking by Value (US$m)
Table 9: Antares Pharma, Inc.: Financial Advisor Ranking by Value (US$m)
Table 10: Antares Pharma, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 11: Antares Pharma, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 12: Antares Pharma, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 13: Antares Pharma, Inc.: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
Table 14: Antares Pharma, Inc.: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
Table 15: Antares Pharma, Inc.: News and Events Summary
Table 16: Antares Pharma, Inc.: Business Expansion
Table 17: Antares Pharma, Inc.: Corporate Governance
Table 18: Antares Pharma, Inc.: Financial Performance
Table 19: Antares Pharma, Inc.: Market Developments
Table 20: Antares Pharma, Inc.: Regulatory and Legal Events
Table 21: Antares Pharma, Inc.: Research & Development
Table 22: Antares Pharma, Inc.: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: Antares Pharma, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 2: Antares Pharma, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 3: Antares Pharma, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 4: Antares Pharma, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 5: Antares Pharma, Inc.: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
Figure 6: Antares Pharma, Inc.: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)